Skip to content

The AMD Experts

teamphoto

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to create AMD Centers of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize is that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: July 9, 2020 | PennLive

‘Most Significant’ Eye Care Innovation…

The AdaptDx Pro may look like a pair of virtual reality goggles, but it's really a device used for catching the early warning signs of age-related macular degeneration (AMD).

Article: July 2020 | Women in Optometry

Turning Losses Into Gains

Leslie Gallagher, OD, FAAO, of Holton, Kansas discusses how a confirmed diagnosis of early or subclinical AMD provides her with the opportunity to discuss optical and nutraceutical needs, which benefit the patient and leads to additional revenue.

Article: June 15, 2020 | Review of Optometry

Shift Focus to Must-see Patients

Even amid COVID-19 worries, caring for patients with retinal disease is a necessity. Optometry needs to focus on essential office visits moving forward, including patients with macular disease.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.